04 May A 30 Year Journey Towards Ibogaine Approval with Dr. Deborah Mash of DemeRx
Posted at 12:02h
in Podcast
Today’s episode features Deborah Mash, founder and CEO of DemeRx, a clinical stage company developing ibogaine therapies to treat substance use disorders.
In this episode, we discuss:
- The science, experience and the safety behind Ibogaine’s “neurochemical reset”
- Navigating US drug regulatory system and securing Intellectual Property
- Deborah’s 30 journey through Amsterdam, Miami and the Caribbean aiming to get Ibogaine therapy approved
- Partnership with ATAI Life Sciences
Listen to full podcast: https://www.businesstrip.fm/podcast/episode/4b6e8d4b/a-30-year-journey-towards-ibogaine-approval-deborah-mash-ceo-of-demerx